Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Polymetal completed the second tranche of the share swap

5/6/24 POLY

Polymetal's sales in Q1 decreased by 7%

5/6/24 POLY

Board of Directors of Rosseti Ural recommended that dividends

5/6/24 MRKU

PIK reported for 2023 by IFRS

5/3/24 PIKK

Softline reported for 3 months of 2024 by RAS

5/3/24 SOFL

Sistema reported for 3 months of 2024 by RAS

5/3/24 AFKS

RESK reported for 3 months of 2024 by RAS

5/3/24 RZSB

Moscow Exchange summarized the results of trading in April

5/3/24 MOEX

MGTS reported for 3 months of 2024 by RAS

5/3/24 MGTS

Zvezda reports for 2023 by IFRS

5/3/24 ZVEZ